: 1 tablet contains:
active substance acetylsalicylic acid 150 mg
excipients: corn starch, cellulose powder, sodium starch glycolate, hypromellose, methacrylic acid copolymer, triethyl citrate, titanium dioxide, talc, sodium lauryl sulfate, lakes with red cochineal E-124, colloidal silica, sodium bicarbonate.
Preparation platelet aggregation inhibitor, intended for long term use in diseases that threaten clots and emboli in vessels.
The enteric coated tablet formulation Polocard® does not disintegrate in the stomach, thereby reducing the irritant effect of acetylsalicylic acid on the gastric mucosa.
Inhibition of platelet aggregation:
in the prevention of cardiovascular diseases, which threaten clots and emboli in blood vessels, myocardial infarction, uncompensated and compensated coronary heart disease;
in the prevention of other diseases involving blood clots in the vessels.
Preventive 1 tablet. 150 mg daily during or after a meal. The tablets should be swallowed whole with a small amount of water.